Alteogen Inc.

Biotech firm developing next-gen ADCs and biobetters with proprietary platform technologies.

196170 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 대전광역시 유성구 유성대로1628번길 62 (전민동 461-38번지), 대전광역시
Website:: http://www.alteogen.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Alteogen Inc. is a biotechnology company focused on the research and development of next-generation biopharmaceuticals, including long-acting biobetters, antibody-drug conjugates (ADCs), and biosimilars. The company leverages a portfolio of proprietary platform technologies to improve existing biologic therapies. Its core technologies include Hybrozyme™, which enables the conversion of intravenous formulations to subcutaneous injections for enhanced patient convenience; NexP™ Fusion, a technology for creating long-acting biologics; and NexMab™, an ADC platform designed for superior stability and efficacy. Through these innovations, Alteogen aims to deliver therapies with enhanced efficacy, durability, and safety profiles.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Alteogen Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Alteogen Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Alteogen Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Cannovum Cannabis AG Importer & producer of medical cannabis, expanding into recreational cultivation infrastructure.	Germany	27N0
Cantourage Group SE A European platform producing and distributing medical cannabis products to pharmacies.	Germany	HIGH
CAREGEN CO.,LTD. Develops patented peptides and growth factors for medical aesthetics, pharma, and anti-aging markets.	South Korea	214370
CELADON PHARMACEUTICALS PLC Vertically integrated pharma developing cannabis medicines for chronic pain.	United Kingdom	CEL
Celemics, Inc. Develops custom NGS panels and bioinformatics for research and clinical diagnostics.	South Korea	331920
Cellbion Co., Ltd Develops & manufactures radiopharmaceuticals for cancer diagnosis and therapy.	South Korea	308430
CELL BIOTECH CO ., LTD A global biotech firm offering probiotic raw materials, OEM/ODM services, and consumer brands.	South Korea	049960
Cellectis Develops 'off-the-shelf' CAR T-cell cancer immunotherapies using TALEN® gene-editing.	France	ALCLS
Cellid Co., Ltd. Biotech firm developing proprietary vaccine platforms for cancer and infectious diseases.	South Korea	299660
Cellromax Science Co., Ltd. Develops health foods, derma-cosmetics, and OTC drugs for pharmacies and online channels.	South Korea	471820